Milestone Pharmaceuticals Inc. (MIST) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 88 transactions totaling $74.1M, demonstrating a bullish sentiment with $28.7M in net insider flow. The most recent transaction on Jan 26, 2026 involved a transaction of 66,600 shares valued at $0.
No significant insider buying has been recorded for MIST in the recent period.
No significant insider selling has been recorded for MIST in the recent period.
Based on recent SEC filings, insider sentiment for MIST is bullish with an Insider Alignment Score of 69/100 and a net flow of $28.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Milestone Pharmaceuticals Inc. (MIST) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading MIST stock, having executed 88 transactions in the past 90 days. The most active insider is Investments, Lp Rtw (Executive), who has made 13 transactions totaling $45.6M.
Get notified when executives and directors at MIST file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | Oliveto Joseph | Executive | Option Exercise | 66,600 | $N/A | $0 | |
| Jan 26, 2026 | Oliveto Joseph | Executive | Sale | 34,523 | $1.93 | $66.6K | |
| Jan 26, 2026 | Oliveto Joseph | Executive | Option Exercise | 66,600 | $N/A | $0 | |
| Jan 26, 2026 | Hasija Amit | CFO & EVP of Corp. Development | Option Exercise | 20,100 | $N/A | $0 | C-Suite |
| Jan 26, 2026 | Hasija Amit | CFO & EVP of Corp. Development | Sale | 12,245 | $1.93 | $23.6K | C-Suite |
| Jan 26, 2026 | Hasija Amit | CFO & EVP of Corp. Development | Option Exercise | 20,100 | $N/A | $0 | C-Suite |
| Jan 26, 2026 | Muller Lorenz | Chief Commercial Officer | Option Exercise | 20,100 | $N/A | $0 | |
| Jan 26, 2026 | Muller Lorenz | Chief Commercial Officer | Sale | 11,180 | $1.93 | $21.6K | |
| Jan 26, 2026 | Muller Lorenz | Chief Commercial Officer | Option Exercise | 20,100 | $N/A | $0 | |
| Jan 26, 2026 | Edward Nelson Jeffrey | Chief Operating Officer | Option Exercise | 20,100 | $N/A | $0 | C-Suite |
| Jan 26, 2026 | Edward Nelson Jeffrey | Chief Operating Officer | Sale | 12,245 | $1.93 | $23.6K | C-Suite |
| Jan 26, 2026 | Edward Nelson Jeffrey | Chief Operating Officer | Option Exercise | 20,100 | $N/A | $0 | C-Suite |
| Jan 26, 2026 | Bharucha David | Chief Medical Officer | Option Exercise | 20,100 | $N/A | $0 | |
| Jan 26, 2026 | Bharucha David | Chief Medical Officer | Sale | 12,245 | $1.93 | $23.6K | |
| Jan 26, 2026 | Bharucha David | Chief Medical Officer | Option Exercise | 20,100 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 25 | $51.4M | 69.1% |
Sale(S) | 14 | $22.7M | 30.6% |
Exercise(M) | 21 | $217.7K | 0.3% |
Award(A) | 17 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Conversion(C) | 8 | $0 | 0.0% |
Insiders at Milestone Pharmaceuticals Inc. are accumulating shares at an accelerated pace. With 17 insiders making 88 transactions totaling $51.4M in purchases versus $22.7M in sales, the net buying activity of $28.7M signals strong executive confidence. Investments, Lp Rtw (Executive) leads the buying activity with $45.6M in transactions across all time.